These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21939467)

  • 1. Deep brain stimulation for early-stage Parkinson's disease: an illustrative case.
    Gill CE; Allen LA; Konrad PE; Davis TL; Bliton MJ; Finder SG; Tramontana MG; Kao CC; Remple MS; Bradenham CH; Charles PD
    Neuromodulation; 2011; 14(6):515-21; discussion 521-2. PubMed ID: 21939467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.
    Charles D; Konrad PE; Neimat JS; Molinari AL; Tramontana MG; Finder SG; Gill CE; Bliton MJ; Kao C; Phibbs FT; Hedera P; Salomon RM; Cannard KR; Wang L; Song Y; Davis TL
    Parkinsonism Relat Disord; 2014 Jul; 20(7):731-7. PubMed ID: 24768120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eleven-Year Outcomes of Deep Brain Stimulation in Early-Stage Parkinson Disease.
    Hacker ML; Meystedt JC; Turchan M; Cannard KR; Harper K; Fan R; Ye F; Davis TL; Konrad PE; Charles D
    Neuromodulation; 2023 Feb; 26(2):451-458. PubMed ID: 36567243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.
    van Horne CG; Quintero JE; Slevin JT; Anderson-Mooney A; Gurwell JA; Welleford AS; Lamm JR; Wagner RP; Gerhardt GA
    J Neurosurg; 2018 Dec; 129(6):1550-1561. PubMed ID: 29451447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson's disease.
    Zhang F; Wang F; Li W; Wang N; Han C; Fan S; Li P; Xu L; Zhang J; Meng F
    BMC Neurol; 2021 Mar; 21(1):122. PubMed ID: 33731033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease.
    Hacker ML; DeLong MR; Turchan M; Heusinkveld LE; Ostrem JL; Molinari AL; Currie AD; Konrad PE; Davis TL; Phibbs FT; Hedera P; Cannard KR; Drye LT; Sternberg AL; Shade DM; Tonascia J; Charles D
    Neurology; 2018 Jul; 91(5):e463-e471. PubMed ID: 29959266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.
    Tramontana MG; Molinari AL; Konrad PE; Davis TL; Wylie SA; Neimat JS; May AT; Phibbs FT; Hedera P; Gill CE; Salomon RM; Wang L; Song Y; Charles D
    J Parkinsons Dis; 2015; 5(1):151-63. PubMed ID: 25613351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral deep brain stimulation of the subthalamic nucleus for Parkinson disease.
    Slowinski JL; Putzke JD; Uitti RJ; Lucas JA; Turk MF; Kall BA; Wharen RE
    J Neurosurg; 2007 Apr; 106(4):626-32. PubMed ID: 17432714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.
    Dafsari HS; Dos Santos Ghilardi MG; Visser-Vandewalle V; Rizos A; Ashkan K; Silverdale M; Evans J; Martinez RCR; Cury RG; Jost ST; Barbe MT; Fink GR; Antonini A; Ray-Chaudhuri K; Martinez-Martin P; Fonoff ET; Timmermann L;
    Brain Stimul; 2020; 13(6):1697-1705. PubMed ID: 33038595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.
    Garcia-Garcia D; Guridi J; Toledo JB; Alegre M; Obeso JA; Rodríguez-Oroz MC
    J Neurosurg; 2016 Nov; 125(5):1068-1079. PubMed ID: 26848922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
    Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
    J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
    Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
    Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in advanced Parkinson's disease after bilateral subthalamic stimulation: 2 years follow-up study.
    Sobstyl M; Ząbek M; Górecki W; Mossakowski Z
    Clin Neurol Neurosurg; 2014 Sep; 124():161-5. PubMed ID: 25051167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach.
    Aviles-Olmos I; Kefalopoulou Z; Tripoliti E; Candelario J; Akram H; Martinez-Torres I; Jahanshahi M; Foltynie T; Hariz M; Zrinzo L; Limousin P
    J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1419-25. PubMed ID: 24790212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.